The invention relates to the field of the chemical and pharmaceutical industry and medicine, and concerns methods for producing new formulations of neuroleptics. The present pharmaceutical composition containing alimemazine tartrate and excipients is characterised in that the following are selected as excipients : microcrystalline cellulose, hypromellose, colloidal silicon dioxide and magnesium stearate.